Koji Mita

894 citations
62 papers · 606 indexed · h-index 16

Koji Mita

60 papers receiving 590 citations

Peers

Koji Mita
Comparison fields: 5 of 77
  • Urology 97
  • Pulmonary and Respiratory Medicine 313
  • Oncology 168
  • Surgery 201
  • Cancer Research 64
Replace Michael R. Abern with:
Michael R. Abern United States
Lydia T Madsen United States
Thomas Krebs Germany
Jairam R. Eswara United States
Gianni Vittori Italy
Antonio D’Amico Italy
M. Nurmi Finland
Christine Sam Austria
Özgür Yaycıoğlu Türkiye
Ronald L. Yap United States
Koji Mita relative to Michael R. Abern United States Michael R. Abern's profile →
Citations per field
00.5×1.5×
Michael R. Abern · 1×
Citations per year

Countries citing papers authored by Koji Mita

Since Specialization
Citations

This map shows the geographic impact of Koji Mita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Mita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Mita more than expected).

Fields of papers citing papers by Koji Mita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Mita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Mita. The network helps show where Koji Mita may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Koji Mita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Koji Mita Line = papers co-authored together Koji Mita links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20225
3 20227
4 20223
5 202111
6 20194
7 201814
8 201824
9 201512
10 201516
11 200911
12 20094
13 200840
14 20064
15 200620
16 20052
17 20048
18 20031
19 200034
20 19946

About Koji Mita

Koji Mita is a scholar working on Urology, Pulmonary and Respiratory Medicine, Oncology, Nephrology and Pediatrics, Perinatology and Child Health, having authored 62 papers that have together received 606 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (9 papers), Urinary Bladder and Prostate Research (7 papers), Renal and related cancers (7 papers), Pediatric Urology and Nephrology Studies (7 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). The work is most often cited by research in Urology (97 citations), Pulmonary and Respiratory Medicine (313 citations), Oncology (168 citations), Surgery (201 citations) and Cancer Research (64 citations). Koji Mita has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Akio Matsubara, Tsuguru Usui, Masanobu Shigeta, Jun Teishima, Masao Katô, Kohei Kobatake, Yasuhisa Hasegawa, Tetsutaro Hayashi, Shinya Ohara and Shogo Inoue. Their work appears in journals such as International Journal of Urology, Urologic Oncology Seminars and Original Investigations, Japanese Journal of Clinical Oncology, Surgery Today and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026